Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav Replacement Therapy in Glaucoma and Ocular Hypertension
NCT01327599Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, pigmentary glaucoma (PG), sponsored by Alcon Inc.. Started Aug 2011; status: completed.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT01327599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327599.